infectious diseases | pharmaphorum

Thursday 30 April 2026

infectious diseases

News

GSK eyes October FDA verdict on chronic hep B drug

GSK eyes October FDA verdict on chronic hep B drug

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a verdict by 26th October.

News

Petri dish of mould

Scientists issue call to arms over antifungal resistance

Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.

News

Petri dish on a black background

EU invests €30m to fight antimicrobial resistance

The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.

News

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Missing the primary endpoint in a phase 3 trial will not stop Pfizer from submitting Valneva-partnered Lyme disease vaccine for approval.

News

Hope rises for vaccine against hookworm parasite

Hope rises for vaccine against hookworm parasite

Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.

News

Meningitis outbreak in UK prompts call to widen vaccination

Meningitis outbreak in UK prompts call to widen vaccination

A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.